Responsibility

Responsible for ensuring that they are connected to NMVS and verify and report medicinal packages in accordance with the Counterfeiting Directive

• Responsible for receiving and implementing certificates and passwords associated with each individual pharmacy’s access to NMVS

• Responsible for ensuring that EIK is connected to NMVS with the correct version of the interface

The European Medicines Verification Organization (EMVO) manages the central “European hub” that connects all the national databases in Europe and acts as the platform to allow medicines anywhere in the EU supply chain to be verified.

Responsible for ensuring that they are connected to NMVS and verify and decommission medicinal packages in accordance with the Falsified Medicines Directive (FMD).

Supreme body responsible for Norways compliance with the Falsified Medicines Directive (FMD).

• Provider of a solution for end-user connection to NMVS
• Responsible for testing and validating their integration with NMVS by using the Baseline Tests provided in the SWS-Portal

NoMVO is a non-commercial (non-profit) organization whose purpose is to be the decision-making body for the implementation, management and operation of the Norwegian medicines verification system set up to fulfil EU 2016/163 in order to avoid counterfeit medicines entering the distribution chain. NoMVO (Norwegian Medicines Verification Organization) is led by a board where all interest organizations (stakeholders) are represented. The members are appointed by the respective interest organisation, and are formally approved at the general assembly.

Nomvec AS is a non-commercial company (non-profit) which develops, operates and maintains the Norwegian medicines verification system (NMVS) according to EU 2016/163, and which assists end users, manufacturers and NOMA (The Norwegian Medicines Agency) in clarifying and analyzing non-conformity messages in the system.

Nomvec has agreements with MAHs and collects payment for the system. Nomvec also verifies and checks the legitimacy of all pharmacies, wholesalers, hospital departments, NCAs and other persons and companies who wish and/or are obliged to have access to NMVS. 

• Responsible for first-line support for all end users in NMVS
• Responsible for distributing the “alertutsendelse” 3 times a week

• Responsible supervisory authority for compliance with the Falsified Medicines Directive (FMD).
• Has access to authority reports  and the ability to examine all alerts generated by Norwegian end users and to monitor compliance with the directive

Responsible for ensuring that they are connected to NMVS and verify and decommission medicinal packages in accordance with the Falsified Medicines Directive (FMD).